GENSEN stock analysis (KOSPI)Common falling wedge pattern.
Big falling wedge with lower trading volumes in a very long period.
−925 KRW
−77.77 B KRW
40.20 B KRW
71.34 M
About GENEONELIFESCIENCE
Sector
Industry
CEO
Young-Geun K. Park
Website
Headquarters
Seoul
Founded
1976
ISIN
KR7011000007
FIGI
BBG000BDV0K1
GeneOne Life Science, Inc. engages in the research, development, and manufacture of deoxyribonucleic acid (DNA) vaccines for the prevention and treatment of diseases. Its products include VGX-3400, VGX-3500, and fluorine. Its service includes process cost analysis, sterility testing, research batch production, strain selection, cell bank characterization, and others. It also conducts pre-clinical trials for the treatment of hepatitis C. In addition, it is involved in contract manufacturing activities for pre-clinical and clinical trials for companies and institutions. The company was founded on January 27, 1976 and is headquartered in Seoul, South Korea.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 011000 is 1,995 KRW — it has decreased by −1.72% in the past 24 hours. Watch GENEONELIFESCIENCE stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange GENEONELIFESCIENCE stocks are traded under the ticker 011000.
011000 stock has fallen by −5.00% compared to the previous week, the month change is a −8.90% fall, over the last year GENEONELIFESCIENCE has showed a −29.63% decrease.
011000 reached its all-time high on Jul 8, 2021 with the price of 37,795 KRW, and its all-time low was 295 KRW and was reached on May 17, 2004. View more price dynamics on 011000 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
011000 stock is 2.16% volatile and has beta coefficient of −0.07. Track GENEONELIFESCIENCE stock price on the chart and check out the list of the most volatile stocks — is GENEONELIFESCIENCE there?
Today GENEONELIFESCIENCE has the market capitalization of 159.26 B, it has decreased by −0.47% over the last week.
Yes, you can track GENEONELIFESCIENCE financials in yearly and quarterly reports right on TradingView.
011000 net income for the last quarter is −10.60 B KRW, while the quarter before that showed −12.81 B KRW of net income which accounts for 17.20% change. Track more GENEONELIFESCIENCE financial stats to get the full picture.
No, 011000 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 22, 2024, the company has 78.00 employees. See our rating of the largest employees — is GENEONELIFESCIENCE on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. GENEONELIFESCIENCE EBITDA is −27.16 B KRW, and current EBITDA margin is −88.53%. See more stats in GENEONELIFESCIENCE financial statements.
Like other stocks, 011000 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade GENEONELIFESCIENCE stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So GENEONELIFESCIENCE technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating GENEONELIFESCIENCE stock shows the sell signal. See more of GENEONELIFESCIENCE technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.